Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A simplified CD34+ based preharvest prediction tool for HPC(A) collection.

Reuben P Jacob1, Eileen M Walsh1, Peter G Maslak1,2

  • 1Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Transfusion
|March 11, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD8<sup>+</sup>CD38<sup>+</sup> T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates.

Blood neoplasia·2026
Same author

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

Blood·2026
Same author

Calcium and Other Electrolyte Management in Patients Undergoing Leukocytapheresis Collections: Review and Recommendations From the American Society for Apheresis Clinical Applications Committee.

Journal of clinical apheresis·2026
Same author

ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

Research square·2026
Same author

Does opioid replacement therapy for infants with prenatal opioid exposure modify the risk of ADHD in childhood? A matched cohort analysis.

Drug and alcohol dependence·2026
Same author

The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations.

Transplantation and cellular therapy·2026

A new formula accurately predicts hematopoietic stem cell yields using peripheral blood CD34+ counts. This method improves upon existing predictions for stem cell collection efficiency.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • Flow Cytometry

Background:

  • Hematopoietic stem cell transplantation (HSCT) relies on adequate CD34+ progenitor cell collection.
  • Peripheral blood CD34+ counts (PB CD34+ counts) are used to predict stem cell yields.
  • Current prediction formulas lack standardization.

Purpose of the Study:

  • To develop and validate a novel, accurate formula for predicting CD34+ stem cell yield.
  • To establish a more reliable method for optimizing stem cell collection processes.

Main Methods:

  • Retrospective analysis of PB CD34+ counts and actual CD34+ yields from mobilized donors.
  • Development of a predictive formula using regression analysis.
  • Validation using root mean square error (RMSE) and comparison with existing formulas.
Keywords:
G-CSFHPC collectionHPC mobilizationcollection predictionplerixafor

Related Experiment Videos

Main Results:

  • A formula (y=mx^b) with a high correlation coefficient (r=0.95) was generated and validated.
  • The formula demonstrated superior accuracy with a lower RMSE (228.4) compared to prior methods (330.8, 405.2).
  • Subset analyses showed improved prediction accuracy in specific patient groups (males, lymphoma, >60 years).

Conclusions:

  • A simple, robust formula accurately predicts CD34+ stem cell yield for autologous and allogeneic donors.
  • The formula incorporates recipient weight for enhanced prediction accuracy.
  • This tool can prospectively guide stem cell collection procedures.